Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • About
  • Communities & Collections
  • Advanced Search
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine
  4. Characterisation of the urinary metabolic profile of liver fluke-associated cholangiocarcinoma
 
  • Details
Characterisation of the urinary metabolic profile of liver fluke-associated cholangiocarcinoma
File(s)
1-s2.0-S0973688319301616-main.pdf (4.95 MB)
Published version
Author(s)
Alsaleh, Munirah
Sithithaworn, Paiboon
Khuntikeo, Narong
Loilome, Watcharin
Yongvanit, Puangrat
more
Type
Journal Article
Abstract
Background Human infection with Opisthorchis viverrini, a carcinogenic liver fluke inhabiting the biliary tree, is endemic in South-East Asia. Chronic infection is associated with a fatal complication, cholangiocarcinoma, a late-presenting and aggressive malignancy. Currently, annual mortality rates from cholangiocarcinoma mirror trends in incidence, due in part to limited availability of efficient prognostic and early diagnostic biomarkers. With ability to detect thousands of urinary metabolites using metabonomics, the urine metabolome holds great potential in providing an insight into system-level alterations in carcinogenesis and in identifying metabolic markers altered in response to disturbed homeostasis.

Methods Global molecular profiling using reversed-phase ultra-performance liquid-chomatography mass spectrometry (RP-UPLC-MS) was utilised to acquire the urinary spectral profile of 137 Thai subjects (48 at high risk of infection, 41 with O. viverrini infection, 34 periportal fibrosis and 14 cholangiocarcinoma) from Khon Kaen, Thailand.

Results Multivariate statistical analysis identified perturbation in several molecular classes related to purine metabolism and lipid metabolism in the cholangiocarcinoma urine metabolome. These markers mainly reflect changes in energy metabolism to support proliferation (increased fatty acid oxidation and purine recycling), DNA methylation and hepatic injury.

Conclusions Several metabolites of biological interest were discovered from this proof-of-principle dataset. Augmenting these findings is essential to accelerate the development of urinary metabolic markers in cholangiocarcinoma.
Date Issued
2019-11
Date Acceptance
2019-06-26
Citation
Journal of Clinical and Experimental Hepatology, 2019, 9 (6), pp.657-675
URI
http://hdl.handle.net/10044/1/72207
URL
https://www.sciencedirect.com/science/article/pii/S0973688319301616?via%3Dihub
DOI
https://www.dx.doi.org/10.1016/j.jceh.2019.06.005
ISSN
0973-6883
Publisher
Elsevier
Start Page
657
End Page
675
Journal / Book Title
Journal of Clinical and Experimental Hepatology
Volume
9
Issue
6
Copyright Statement
© 2019 Indian National Association for Study of the Liver. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Sponsor
Wellcome Trust
Wellcome Trust
Wellcome Trust
Wellcome Trust
Kadoorie Charitable Foundation
Identifier
https://www.sciencedirect.com/science/article/pii/S0973688319301616?via%3Dihub
Grant Number
097816/Z/11/ZR
097816/Z/11/A
097816/Z/11/B
105603/Z/14/Z
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
bile duct cancer
mass spectrometry
metabonomics
Opisthorchis viverrini
HEPATOCELLULAR-CARCINOMA
MASS-SPECTROMETRY
PROLINE BETAINE
BIOMARKERS
QUANTIFICATION
IDENTIFICATION
ACETAMINOPHEN
METABONOMICS
DISCOVERY
CIRRHOSIS
Opisthorchis viverrini
acetaminophen, APAP
bile duct cancer
carnitine palmitoyltransferase 1, CPT1
carnitine palmitoyltransferase 2, CPT2
carnitine/acylcarnitine translocase, CACT
cholangiocarcinoma screening and care program, CASCAP
cholangiocarcinoma, CCA
data-dependent acquisition, DDA
electrospray ionisation, ESI
hypoxanthine phosphoribosyltransferase 1, HPRT1
hypoxanthine-guanine phosphoribosyltransferase, HPRT
mass spectrometry
metabonomics
orthogonal projections to latent structures discriminant analysis, OPLS-DA
periductal fibrosis, PDF
periportal fibrosis, PPF
primary biliary cholangitis, PBC
primary sclerosing cholangitis, PSC
principal component analysis, PCA
reversed-phase ultra-performance liquid-chromatography mass spectrometry, RP-UPLC-MS
ultra-performance liquid chromatography mass spectrometry, UPLC-MS
variable importance in projection, VIP
Publication Status
Published
Date Publish Online
2019-07-31
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback